Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine added to naltrexone maintenance in detoxified adults with opioid dependence
2007-006523-12Phase 4Active
- Sponsor
- Julio Bobes
- Start
- Jan 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of buprenorphine and naltrexone in opioid use disorder (OUD) (2 arms), sponsored by Julio Bobes. Primary endpoints: Treatment retention rate and Confirmation of absence of mu-opioid effect of buprenorphine under naltrexone blockade. Started Jan 2008; status: active.
02
Drugs
buprenorphinenaltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2007-006523-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006523-12.